Clinical Trial Update: An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports a Phase 2 study evaluating maintenance therapy with the antibody-drug conjugate mirvetuximab soravtansine in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Mirvetuximab soravtansine (mirvetuximab soravtansine)
• Olaparib (Olaparib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Ovary Cancer, Peritoneal Cancer | Phase 2 | Status: RECRUITING